A31. Asthma: Clinical Studies I 2019
DOI: 10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a7307
|View full text |Cite
|
Sign up to set email alerts
|

A Predictive Model for Clinical Asthma Exacerbations Using Albuterol eMDPI (ProAir Digihaler): A 12-Week, Open-Label Study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
4
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(4 citation statements)
references
References 0 publications
0
4
0
Order By: Relevance
“…The device is connected via Bluetooth® technology to a companion App that provides information on inhaler use to the patient. While to date, the efficacy of Digihalers has not been evaluated; one pilot study has shown its ability to predict exacerbations [28]. Adults with exacerbation-prone asthma (n = 360) used the ProAir® Digihaler™ for 12 weeks.…”
Section: Use Of Electronic Monitoring Devices In Asthmamentioning
confidence: 99%
“…The device is connected via Bluetooth® technology to a companion App that provides information on inhaler use to the patient. While to date, the efficacy of Digihalers has not been evaluated; one pilot study has shown its ability to predict exacerbations [28]. Adults with exacerbation-prone asthma (n = 360) used the ProAir® Digihaler™ for 12 weeks.…”
Section: Use Of Electronic Monitoring Devices In Asthmamentioning
confidence: 99%
“…A summary of emerging e‐Health solutions for asthma management is provided in Table 2 53,56‐62 . Overall, both digital stand‐alone and combined multicomponent interventions showed promising results on treatment adherence and clinical outcomes.…”
Section: Digital Multicomponent Interventions and Mobile‐healthmentioning
confidence: 99%
“…Another study using electronic monitoring, the Propellor Health pMDI add-on device, revealed that in COPD patients a 100% increase in the use of daily rescue use was significantly associated with an acute exacerbation [76]. Preliminary results from a study investigating the real-life use of the ProAir Digihaler by patients with asthma, who had a history of acute clinical exacerbations [77] has revealed that there is an increased use of salbutamol in the days leading up to an acute exacerbation and modelling of the data identified that increased rescue use and changes in inhalation technique (PIF and Vin) were predictors of an exacerbation. There is, therefore, the potential for smart inhalers to identify an increased use of rescue medication and provide alerts so that interventions can be made to prevent an evolving acute exacerbation.…”
Section: The Potential Of Smart Inhalers To Predict Acute Exacerbationsmentioning
confidence: 99%
“…The reports highlighting the increased rescue use leading up to an acute exacerbation [75][76][77] as well as a deteriorating inhaler technique [77] suggest potential for smart inhalers to warn of an impending acute exacerbation. The role of smart inhalers to send alerts and early interventions needs extensive investigation because this could revolutionise management.…”
Section: Smart Inhalersconsiderations For the Futurementioning
confidence: 99%